Melanoma

CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma

user February 4, 2021

CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of...

Institute for Healthcare Advancement Announces PlainLanguage Pro: A Skill-Building Module That Equips Healthcare Writers, Designers, and Editors of Consumer-Facing Documents with Industry-Leading Health Literacy Best Practices and Principles

Staff November 14, 2024

NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates

Staff November 14, 2024

Swell Launches Employee Experience Insights to Give Healthcare Organizations Real-Time Employee Feedback

Staff November 14, 2024

MDaudit’s 2024 Benchmark Report Reveals a Fivefold Increase in Dollars At-Risk from Payer Audits while Coding-Related Denials Surged by Over 125%

Staff November 14, 2024

Zane Networks Awarded Blanket Purchase Agreement for Health and Human Services’ Health IT Alignment Initiative

Staff November 14, 2024

CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma

You may have missed

Institute for Healthcare Advancement Announces PlainLanguage Pro: A Skill-Building Module That Equips Healthcare Writers, Designers, and Editors of Consumer-Facing Documents with Industry-Leading Health Literacy Best Practices and Principles

NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates

Swell Launches Employee Experience Insights to Give Healthcare Organizations Real-Time Employee Feedback

MDaudit’s 2024 Benchmark Report Reveals a Fivefold Increase in Dollars At-Risk from Payer Audits while Coding-Related Denials Surged by Over 125%

Zane Networks Awarded Blanket Purchase Agreement for Health and Human Services’ Health IT Alignment Initiative